Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 53 results for "julie masow"

Novartis LEE011 (ribociclib) plus letrozole analyses show supe...

World News: 13:30 GMT Friday 9th December 2016 . [ Novartis International AG via Thomson Reuters ONE via SPi World News ] MONALEESA-2 analyses demonstrate superior PFS with LEE011 plus letrozole in pre-defined patient subgroups - from de novo ... SPi World News, 1 day ago
[x]  
Freshnews.com

Novartis announces Zykadia® first-line study results showing 16.6 month progression-free survival in patients with ALK+ advanced NSCLC

- Patients without brain metastases at diagnosis experienced median progression-free survival of 26.3 months, the longest seen in a global Phase III study in ALK+ NSCLC(1)- Patients with measurable brain metastases in the Zykadia arm experienced an ...
 TickerTech.com4 days ago Novartis data shows Treatment-free Remission rates are consistently above 50% regardless of reason for switch to Tasigna® from Gleevec®  Yahoo! Finance5 days ago Novartis presents results from first global registration trial of CTL019 in pediatric and young adult patients with r/r B-ALL  Bio-Medicine6 days ago Novartis drug PKC412 (midostaurin) granted FDA Priority Review for newly-diagnosed FLT3-mutated AML and advanced systemic mastocytosis  BioSpace3 weeks ago
[x]  
Zimbabwe Daily

FACTIONS BRAWL OVER MUGABE PROPHET

The mad-scramble within President Robert Mugabe's warring Zanu PF to control the frail and mysterious leader of a secretive religious sect, Madzibaba Wimbo, is intensifying — with the 94-year-old now living under 24-hour guard by soldiers armed to ...
 Zimbabwe Daily2 weeks ago Zanu-PF factions fight for Mugabe's mysterious prophet  Bulawayo24 News2 weeks ago Soldiers 'cut off' Mugabe prophet  Daily News Zimbabwe2 weeks ago
Freshnews.com

Novartis data at ASH and SABCS showcase latest innovations in development for patients with blood disorders and breast cancer

EAST HANOVER, N.J., Nov. 16, 2016 /PRNewswire/ -- Novartis will present data demonstrating the latest advancements from its oncology research program at the 58 th American Society of Hematology (ASH) Annual Meeting & Exposition, San Diego, December ...
 Yahoo! Singapore3 weeks ago
[x]  
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less